Therapeutic methods employing nitric oxide precursors

Details for Australian Patent Application No. 2012203629 (hide)

Owner Vanderbilt University

Inventors Summar, Marshall L.; Christman, Brian; Barr, Frederick E.

Agent Griffith Hack

Pub. Number AU-A-2012203629

Parent 2009203177

Filing date 21 June 2012

Wipo publication date 12 July 2012

International Classifications

A61K 31/195

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 9/12 Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

12 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203629

12 July 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203630-Gateway platform for biological monitoring and delivery of therapeutic compounds

2012203628-A Support Tray and Pipe Support